Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling pathway (2024-02-02)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: MCF7 [MCF-7] Cells Line -
CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population (2024-06-14)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: KYSE-30 Cells Line, TE-10 Cells Line -
Identifying the mechanism of polysaccharopeptide against breast cancer based on network pharmacology and experimental verification (2024-06-13)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: SUM159PT Cells Line, MDA-MB-231 Cells Line, MCF 10A Cells Line, MCF7 [MCF-7] Cells Line -
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation (2024-07-17)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: Ham's F-12K Medium -
Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes (2024-07-31)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: RPMI-1640 Medium, Fetal Bovine Serum -
The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma (2024-08-01)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: MG-63 Cells Line, U-2 OS [U2OS] Cells Line, 293T [HEK-293T] Cells Line -
The role of tRF-Val-CAC-010 in lung adenocarcinoma: implications for tumorigenesis and metastasis (2024-08-21)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: A549 [A-549] Cells Line, PC-9 Cells Line, BEAS-2B Cells Line -
GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis (2024-09-10)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: A549/DDP Cells Line -
A novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma (2024-09-02)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: Hep G2 Cells Line -
SQLE—a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration (2024-09-11)
Journal: BMC CANCER (2024) IF: 3.4Products Cited: SiHa Cells Line, Hela Cells Line
